Repligen
RGEN
#2699
Rank
C$8.73 B
Marketcap
C$154.80
Share price
-3.68%
Change (1 day)
-19.49%
Change (1 year)
Categories

Earnings for Repligen (RGEN)

Earnings in 2025 (TTM): C$0.11 Billion

According to Repligen 's latest financial reports the company's current earnings are C$0.73 Billion. , an increase over its 2024 earnings that were of -C$8.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Repligen from 1985 to 2025

Annual earnings

Year Earnings Change
2025 C$0.11 B-1430.84%
2024 -C$8.63 Million-113.01%
2023 C$66.3 M-78.01%
2022 C$0.30 B33.37%
2021 C$0.22 B131.52%
2020 C$97.64 M101.31%
2019 C$48.5 M25.93%
2018 C$38.51 M105.61%
2017 C$18.73 M-11.46%
2016 C$21.15 M14.91%
2015 C$18.41 M20.26%
2014 C$15.31 M-51.49%
2013 C$31.56 M90.98%
2012 C$16.52 M
2010 C$0.23 M-103.81%
2009 -C$6.28 Million-223.84%
2008 C$5.06 M
2006 -C$3.41 Million229.64%
2005 -C$1.04 Million-89.16%
2004 -C$9.54 Million-16.86%
2003 -C$11.47 Million88.72%
2002 -C$6.08 Million-27.88%
2001 -C$8.43 Million-1.74%
2000 -C$8.58 Million85.93%
1999 -C$4.62 Million159.16%
1998 -C$1.78 Million85.71%
1997 -C$0.96 Million-70.83%
1996 -C$3.29 Million-72.41%
1995 -C$11.91 Million-60.63%
1994 -C$30.25 Million45.39%
1993 -C$20.81 Million39.45%
1992 -C$14.92 Million-32.3%
1991 -C$22.04 Million6.62%
1990 -C$20.67 Million1577.78%
1989 -C$1.24 Million-57.14%
1988 -C$2.88 Million-362.5%
1987 C$1.09 M-130.77%
1986 -C$3.56 Million136.36%
1985 -C$1.51 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$13.94 B 12,048.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$10.00 B 8,610.78%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$14.83 B 12,824.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.76 B 11,018.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-C$0.15 Billion-229.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$0.51 B 346.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$0.87 B 658.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.16 B 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$0.66 B 475.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
-C$0.14 Billion-218.60%๐Ÿ‡บ๐Ÿ‡ธ USA